Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class ASSE: 603392

Announcement on Acceptance of Clinical Trial Application for Recombinant Trivalent Rotavirus Subunit Vaccine (Escherichia coli)

· Issued by Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Acceptance of Clinical Trial Application for Recombinant Trivalent Rotavirus Subunit Vaccine (Escherichia coli)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis